Moberg Pharma AB (publ) (STO:MOB)

Moberg Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	370	475	425	228	237	143
Market Cap Growth	11.73%	11.73%	86.42%	-3.61%	65.26%	-47.37%
Enterprise Value	81	170	327	87	130	127
Last Close Price	7.92	10.17	15.20	23.20	51.85	56.32
PE Ratio	-	-	-	-	31.57	24.40
Forward PE	-	69.33	69.33	69.33	69.33	69.33
PS Ratio	30.55	48.40	-	1101.38	-	4.25
PB Ratio	0.54	0.69	0.70	0.43	0.55	0.36
P/TBV Ratio	0.69	0.69	0.70	0.43	0.55	0.37
EV/Sales Ratio	8.22	17.28	-	421.77	-	3.76
EV/EBITDA Ratio	-	-	-	-	12.82
EV/EBIT Ratio	-	-	-	-	12.89
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.02
Debt / EBITDA Ratio	-	-	-	-	-	0.60
Asset Turnover	0.02	0.02	-	0	-	-
Inventory Turnover	0.61	0.61	-	-	-	-
Quick Ratio	17.69	17.69	2.99	4.74	6.68	0.27
Current Ratio	17.95	17.95	3.38	4.77	6.74	2.08
Return on Equity (ROE)	-39.32%	-39.32%	-3.69%	-3.25%	-3.91%	-
Return on Assets (ROA)	-30.28%	-30.28%	-2.91%	-2.53%	-2.65%	-
Return on Capital (ROIC)	-31.08%	-31.08%	-3.02%	-2.62%	-2.93%	-
Return on Capital Employed (ROCE)	-	-	-	-	-	2.50%
Earnings Yield	-68.98%	-53.72%	-4.96%	-6.89%	3.17%	4.10%
FCF Yield	-3.47%	-3.47%	-7.81%	-7.39%	-6.47%	-7.27%
Buyback Yield / Dilution	-138.46%	-138.46%	-109.19%	-76.28%	-127.45%	-0.34%

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.